Sunday, December 14, 2025 | 02:48 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Accord Group enters pharma business, targets sales in 18 states

The company has invested around Rs 600 crore into a manufacturing facility in Chennai and plans to invest around Rs 1,500 crore by March 2022, for R&D, acquisitions and others as part of expansion

pharma, medicines, drugs
premium

Gireesh Babu Chennai
Chennai-based Accord Group, which is into diversified interests in medical education, a technical university, hospitals, breweries and hotels, has announced entry into domestic pharma market through Accord Life Spec, a pharmaceutical company it had initiated three years back. The company has invested around Rs 600 crore into a manufacturing facility in Chennai and plans to invest around Rs 1,500 crore by March 2022, for R&D, acquisitions and others as part of expansion.

Accord Group, founded by Dravida Munnetra Kazhagam (DMK) leader and former Union Minister S Jagathrakshakan, has recently bid for the debt-ridden Orchid Pharma under the Corporate Insolvency Resolution